Clinical Trial Update: Neuropathic Pain Management [Phase 3]

View source ↗

Summary

A Phase 3 trial in neuropathic pain management sponsored by Merck KGaA has completed and posted results for diabetic neuropathy and polyneuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Polyneuropathy

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Diabetic Neuropathies, Polyneuropathies | Phase 3 | Status: COMPLETED | Results posted: 2011-10-27